KR870008594A - 베라파밀제형 - Google Patents
베라파밀제형 Download PDFInfo
- Publication number
- KR870008594A KR870008594A KR870001023A KR870001023A KR870008594A KR 870008594 A KR870008594 A KR 870008594A KR 870001023 A KR870001023 A KR 870001023A KR 870001023 A KR870001023 A KR 870001023A KR 870008594 A KR870008594 A KR 870008594A
- Authority
- KR
- South Korea
- Prior art keywords
- verapamil
- formulation
- dosage form
- acylated cellulose
- wall
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/275—Nitriles; Isonitriles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Vascular Medicine (AREA)
- Obesity (AREA)
- Urology & Nephrology (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Abstract
내용 없음
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
제 1 도는 유용한 약물인 베라파밀을 장기간동안 위장관에 경구투여 하도록 형상과 크기를 갖춘 삼투식 제형의 부분도.
제 2 도는 제 1 도의 제형의 구조를 설명하기 위해 절게된 제형의 외축벽의 일부분의 부분적 개방도.
*도면의 주요부분에 대한 부호의 설명
20…제형 21…몸체부재 22…벽 23,24…통로
25…벽의 분활경계 26…격실 27…베라파밀
Claims (11)
- 생물학적 사용환경에 유용한 약물인 베라파밀(verapamil)을 투여하는 제형(dosage form)에 있어서,(a)아실화셀룰로오스를 포함하는 최소한 일부분의 조성물을 포함하는 벽을 포함하며, 이벽은 유체에는 투과성이고, 베라파밀에는 불투과성이며, 제형을 감싸고 형성하며 ;(b)격실을 포함하며 ;(c)전술 베라파밀이 격실에서 만니톨과 함께 0.9 내지 1.1의 비평형비율로 존재하는 조건으로 베라파밀의 투여 양을 격실속에 포함하며 ;(d)베라파밀을 장시간 사용환경으로 투여하기 위해 격실과 제형의 외측을 연결하는 최소한 하나의 통로를 벽속에 포함하는 제형.
- 제 1 항에 있어서, 베라파밀이 치료학적으로 적합한 부가염으로서 존재하게된, 유용한 약물 베라파밀을 투여하는 제형.
- 제 1 항에 있어서, 베라파밀이 베라파밀 염화수소로서 제형속에 존재하게된, 유용한 약물 베라파밀을 투여하는 제형.
- 제 1 항에 있어서, 아실화셀룰로오스가 아세틸함량이 39.8%인 아세트산셀룰로오스로된, 유용한 약물 베라파밀을 투여하는 제형.
- 제 1 항에 있어서, 아실화셀룰로오스가 아세틸함량이 32%인 아세트산셀룰로오스로된, 유용한 약물베라파밀을 투여하는 제형.
- 제 1 항에 있어서, 벽조성물이 아세틸 함량이 39.8%인 아실화셀룰로오스와 아세틸 함량이 32%인 아실화셀룰로오스를 포함하게된, 유용약물 베라파밀을 투여하는 제형.
- 제 1 항에 있어서, 비평형비율이 1이되는, 유용약물 베라파밀을 투여하는 제형.
- 제 1 항에 있어서, 제형이 50내지 600mg의 베라파밀을 포함하는 유용약물 베라파밀을 투여하는 제형.
- 제 1 항에 있어서, 제형이 115 내지 125mg의 약학적으로 적합한 염인 베라파밀을 포함하게된, 유용약물 베라파밀을 투여하는 제형.
- 제 1 항에 있어서, 제형이 235 내지 245mg의 약학적으로 적합한 염인 베라파밀을 포함하게된, 유용약물 베라파밀을 투여하는 제형.
- 제 1 항에 있어서, 위장관에 사용하는 환경에서 이 제형이 이 사용환경 속으로 경구투여 하기에 적합한 유용약물 베라파밀을 투여하는 제형.※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/841,144 US4753802A (en) | 1986-03-19 | 1986-03-19 | Verapamil dosage form |
US841144 | 1986-03-19 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR870008594A true KR870008594A (ko) | 1987-10-19 |
KR900003385B1 KR900003385B1 (ko) | 1990-05-18 |
Family
ID=25284138
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019870001023A KR900003385B1 (ko) | 1986-03-19 | 1987-02-09 | 베라파밀 제형 |
Country Status (12)
Country | Link |
---|---|
US (1) | US4753802A (ko) |
EP (1) | EP0238189B1 (ko) |
JP (1) | JPH0798748B2 (ko) |
KR (1) | KR900003385B1 (ko) |
AT (1) | ATE59549T1 (ko) |
AU (1) | AU587307B2 (ko) |
CA (1) | CA1261703A (ko) |
DE (1) | DE3766858D1 (ko) |
ES (1) | ES2019632B3 (ko) |
GR (1) | GR3001290T3 (ko) |
MX (1) | MX174161B (ko) |
ZA (1) | ZA871031B (ko) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4690683A (en) * | 1985-07-02 | 1987-09-01 | Rutgers, The State University Of New Jersey | Transdermal varapamil delivery device |
US4816263A (en) * | 1987-10-02 | 1989-03-28 | Alza Corporation | Dosage form for treating cardiovascular diseases comprising isradipine |
US4859470A (en) * | 1988-06-02 | 1989-08-22 | Alza Corporation | Dosage form for delivering diltiazem |
JPH04503058A (ja) * | 1989-01-30 | 1992-06-04 | アルザ コーポレイション | カルシウム拮抗体投与のための剤形 |
DD295760A5 (de) * | 1989-01-31 | 1991-11-14 | Martin-Luther-Universitaet Halle Wittenberg,De | Arzneistoffreigabesystem mit kotrollierter wirkstoffreisetzung |
FI900470A0 (fi) * | 1989-01-31 | 1990-01-30 | Int Pharma Agentur | Aktivaemnen kontrollerat avgivande system och foerfarande foer dess framstaellning. |
US5364635A (en) * | 1989-09-28 | 1994-11-15 | Knoll Ag | Solid drug form with a high verapamil content |
NZ238867A (en) * | 1990-07-12 | 1993-08-26 | Alza Corp | Dosage form for delayed release comprising pharmaceutically active substance and a drug-release hindering means and a second composition which imbibes fluid, expands, and ejects the active substance from the device |
US6764697B1 (en) | 1991-06-27 | 2004-07-20 | Alza Corporation | System for delaying drug delivery up to seven hours |
US5160744A (en) * | 1991-06-27 | 1992-11-03 | Alza Corporation | Verapmil therapy |
US5435998A (en) * | 1994-08-03 | 1995-07-25 | Abelson; Mark B. | Treatment of low-tension glaucoma by topical administration of calcium channel blocking agents |
US5695781A (en) * | 1995-03-01 | 1997-12-09 | Hallmark Pharmaceuticals, Inc. | Sustained release formulation containing three different types of polymers |
US6083532A (en) | 1995-03-01 | 2000-07-04 | Duramed Pharmaceuticals, Inc. | Sustained release formulation containing three different types of polymers and tablet formed therefrom |
US6096339A (en) * | 1997-04-04 | 2000-08-01 | Alza Corporation | Dosage form, process of making and using same |
UA74141C2 (uk) | 1998-12-09 | 2005-11-15 | Дж.Д. Сірл Енд Ко. | Фармацевтична композиція на основі тонкоподрібненого еплеренону (варіанти), спосіб її одержання та спосіб лікування розладів, опосередкованих альдостероном (варіанти) |
US7108866B1 (en) | 1999-12-10 | 2006-09-19 | Biovall Laboratories International Srl | Chronotherapeutic diltiazem formulations and the administration thereof |
US20060153914A1 (en) * | 1999-12-10 | 2006-07-13 | Biovail Laboratories International S.R.L. | Chronotherapeutic diltiazem formulations and the administration thereof |
JP4848101B2 (ja) * | 2001-08-17 | 2011-12-28 | 株式会社フジモト・コーポレーション | 徐放性マイクロペレット |
US20040005359A1 (en) * | 2002-06-27 | 2004-01-08 | Cheng Xiu Xiu | Controlled release oral dosage form |
CA2547137A1 (en) | 2003-11-25 | 2005-06-09 | Sb Pharmco Puerto Rico Inc. | Carvedilol free base, salts, anhydrous forms or solvates thereof, corresponding pharmaceutical compositions, controlled release formulations, and treatment or delivery methods |
WO2005051325A2 (en) * | 2003-11-25 | 2005-06-09 | Sb Pharmco Puerto Rico Inc. | Carvedilol compositions methods of treatment and delivery |
DE102005031868A1 (de) * | 2005-07-04 | 2007-01-18 | Biotronik Vi Patent Ag | Arzneimitteldepot zur parenteralen, insbesondere intravaskulären Arzneimittelfreisetzung |
CA2789065A1 (en) * | 2010-03-23 | 2011-09-29 | Lintec Corporation | Solid preparation |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4265874A (en) * | 1980-04-25 | 1981-05-05 | Alza Corporation | Method of delivering drug with aid of effervescent activity generated in environment of use |
US4681583A (en) * | 1982-12-20 | 1987-07-21 | Alza Corporation | System for dispersing drug in biological environment |
US4627850A (en) * | 1983-11-02 | 1986-12-09 | Alza Corporation | Osmotic capsule |
GB2150830B (en) * | 1983-12-05 | 1987-08-19 | Alza Corp | Drug dispenser |
CA1266827A (en) * | 1984-06-20 | 1990-03-20 | Merck & Co., Inc. | Controlled porosity osmotic pump |
-
1986
- 1986-03-19 US US06/841,144 patent/US4753802A/en not_active Expired - Lifetime
-
1987
- 1987-02-09 KR KR1019870001023A patent/KR900003385B1/ko not_active IP Right Cessation
- 1987-02-10 ES ES87301155T patent/ES2019632B3/es not_active Expired - Lifetime
- 1987-02-10 DE DE8787301155T patent/DE3766858D1/de not_active Expired - Lifetime
- 1987-02-10 EP EP87301155A patent/EP0238189B1/en not_active Expired - Lifetime
- 1987-02-10 AT AT87301155T patent/ATE59549T1/de not_active IP Right Cessation
- 1987-02-12 AU AU68715/87A patent/AU587307B2/en not_active Expired
- 1987-02-12 ZA ZA871031A patent/ZA871031B/xx unknown
- 1987-03-18 JP JP62063660A patent/JPH0798748B2/ja not_active Expired - Fee Related
- 1987-03-18 CA CA000532296A patent/CA1261703A/en not_active Expired
-
1991
- 1991-01-09 GR GR90400657T patent/GR3001290T3/el unknown
-
1992
- 1992-06-26 MX MX9203557A patent/MX174161B/es unknown
Also Published As
Publication number | Publication date |
---|---|
KR900003385B1 (ko) | 1990-05-18 |
JPH0798748B2 (ja) | 1995-10-25 |
ES2019632B3 (es) | 1991-07-01 |
AU587307B2 (en) | 1989-08-10 |
MX9203557A (es) | 1992-09-01 |
US4753802A (en) | 1988-06-28 |
GR3001290T3 (en) | 1992-08-26 |
ZA871031B (en) | 1987-08-04 |
AU6871587A (en) | 1987-09-24 |
EP0238189A1 (en) | 1987-09-23 |
ATE59549T1 (de) | 1991-01-15 |
EP0238189B1 (en) | 1991-01-02 |
JPS62226924A (ja) | 1987-10-05 |
DE3766858D1 (de) | 1991-02-07 |
CA1261703A (en) | 1989-09-26 |
MX174161B (es) | 1994-04-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR870008594A (ko) | 베라파밀제형 | |
KR880002502A (ko) | 산에 민감한 유익한 약제의 투여용 제형(劑形) | |
KR870008583A (ko) | 슈도에페드린, 브롬페니라민 요법 | |
KR880002515A (ko) | 흡수 및 작용이 빠른 설린다크 또는 나트륨 설린다크와 염기의 혼합물 | |
KR890004684A (ko) | 신속 방출제 전달계와 완속 방출제 전달계로 된 제형(劑刑) | |
KR930700076A (ko) | 항파킨슨제를 전달하기 위한 제형 | |
KR920702216A (ko) | 아세틸 d-카르니틴의 녹내장 치료에의 용도 | |
DK195490A (da) | Dispenser for pulverformige medikamenter | |
ES2048594T3 (es) | Formulaciones farmaceuticas. | |
ATE214289T1 (de) | Pernasale zusammensetzung und diese enthaltende pernasale zubereitung | |
KR880009634A (ko) | 슈도에페드린 브롬페니라민 요법의 개량 | |
KR870010866A (ko) | 펄프(pulse)식 약제 전달용 투약형상체 | |
ES2040789T3 (es) | Formas de administracion retardantes envueltas. | |
KR890009376A (ko) | 분무 건조된 이부프로펜 | |
KR850700212A (ko) | 서방성 약제학적 캼셀제 | |
KR970025615A (ko) | 암 전이 억제제 | |
KR900000076A (ko) | 딜티아젬(diltiazem) 공급용의 제형(dosage form) | |
MX9205568A (es) | Composicion farmaceutica que contiene cantidades de 5-amino-1beta-d-ribofuranosil-imidazol-4-carboxamida. | |
KR830002510A (ko) | 생물학적 활성화합물과 하이드록시알킬 전분으로 구성되는 조성물 | |
KR870009716A (ko) | 클로르페니라민 제형 | |
KR950013513A (ko) | 약제 제조용 모에노마이신 및 이의 유도체, 및 모에노마이신 또는 이의 유도체를 함유하는 약제 | |
KR870010082A (ko) | 구아르(guar) 분말 | |
KR890003386A (ko) | 항 고지방 혈증제 | |
KR890007728A (ko) | 진통제 제조방법 | |
KR910004186A (ko) | 제약학적 배합물 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
G160 | Decision to publish patent application | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20020509 Year of fee payment: 13 |
|
LAPS | Lapse due to unpaid annual fee |